1. Home
  2. ATCX vs RGNT Comparison

ATCX vs RGNT Comparison

Compare ATCX & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATCX

Atlas Critical Minerals Corporation Common Stock

N/A

Current Price

$5.50

Market Cap

23.8M

Sector

N/A

ML Signal

N/A

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$2.96

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATCX
RGNT
Founded
2016
2004
Country
Brazil
Israel
Employees
13
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.8M
20.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATCX
RGNT
Price
$5.50
$2.96
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$13.75
N/A
AVG Volume (30 Days)
33.1K
3.5K
Earning Date
03-16-2023
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$827,667.00
N/A
Revenue Next Year
$166.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.39
$2.80
52 Week High
$14.01
$8.35

Technical Indicators

Market Signals
Indicator
ATCX
RGNT
Relative Strength Index (RSI) 48.42 38.34
Support Level $5.32 $2.80
Resistance Level $6.46 $3.35
Average True Range (ATR) 0.68 0.16
MACD 0.04 0.06
Stochastic Oscillator 48.21 3.04

Price Performance

Historical Comparison
ATCX
RGNT

About ATCX Atlas Critical Minerals Corporation Common Stock

Atlas Critical Minerals Corp is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: